Plunkett Research Online: Aegerion Pharmaceuticals Inc

AEGERION PHARMACEUTICALS INC (AEGR) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aegerion Pharmaceuticals Inc is an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders. It is a development stage company. The Company is initially developing its compound, lomitapide, as an oral, once-a-day trea.....


AEGERION PHARMACEUTICALS INC

Ticker: AEGR
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 908 707-2100
Fax:
Address: CenterPointe IV
Bridgewater, NJ 08807 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Benjamin HarshbargerAssistant General Counsel/Secretary
Gregory PerryCFO/Chief Administrative Officer
See More
Aegerion Pharmaceuticals Inc is an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders. It is a development stage company. The Company is initially developing its compound, lomitapide, as an oral, once-a-day trea.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture